MSCM
MRTX

McElhenny Sheffield Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$227 – 653
2022
Q4 		$227 Buy
+5
New +$227 ﹤0.01% 654